Only a small percentage of people in the U.S. with opioid use disorder (OUD) are receiving needed treatments (e.g., buprenorphine and methadone), according to the 2022 National Survey on Drug Use and Health. According to summary findings in the report:
- "In 2022, among the 4% of U.S. adults who needed OUD treatment, only 25% received recommended medications."
- "A larger percentage (30%) received treatment without medications."
- "In 2022, 81,806 opioid-involved overdose deaths were reported in the United States, more than in any previous year. Medications for opioid use disorder (OUD), particularly buprenorphine and methadone, substantially reduce overdose-related and overall mortality."
Read more in Treatment for Opioid Use Disorder: Population Estimates — United States, 2022 (CDC, June 27, 2024).
Access our resources on Substance Use & Addiction.